Takeda, TWi settlement supports US antitrust claims, plaintiffs say
MLex Summary: US antitrust claims against Takeda Pharmaceutical and TWi Pharmaceuticals alleging an illegal reverse payment agreement to restrain competition for Dexilant and its generic equivalents should move forward, Walgreens, Kroger, Albertsons, and...To view the full article, register now.
Already a subscriber? Click here to view full article